About LDNscience
LDNscience™ is a public information project of the MedInsight® Research Institute. The MedInsight® Research Institute is a U.S.-based 501(c)(3) nonprofit working to bridge the ever-widening gap between medical research and actual medical practice. We are dedicated to bringing relief to those who suffer from cancer or chronic medical conditions by raising awareness of:
MedInsight's co-founder, Moshe Rogosnitzky, is an expert in the clinical application of Low Dose Naltrexone (LDN), Opioid Growth Factor (OGF) and related therapies, which have made incredible inroads with Crohn’s disease, cancer and other serious diseases. He collaborates in research with the discoverers of LDN and OGF, Dr. Ian S. Zagon and Dr. Patricia J. McLaughlin of Hershey Medical Center, Penn State University, as well as with Dr. Jill P. Smith of Hershey Medical Center, who conducts clinical research into LDN and OGF. This site is intended to provide you with general information on the background, use of and evidence for LDN, OGF and related therapies, and to answer any questions on these therapies and our work. If you cannot find the answer to your particular question, please submit your question and we will respond to you as soon as possible. To become a much-valued supporter of this site or of our life-changing research into LDN, OGF and related therapies, please visit: Join Our Supporters. Thank you, The LDNscience™ Team 
|
»»We are currently seeking an Outreach Ambassador to help us raise public awareness. If you are savvy about social media and passionate about the cause, please take a moment to learn more about this volunteer position.
